Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial on the Treatment of Hypertensive Intracerebral Hemorrhage With Naoxuekang Dropping Pills [Phase 2]

View source ↗

Summary

A Phase 2 multicenter, randomized, double-blind, placebo-controlled trial evaluating Naoxuekang Dropping Pills for hypertensive intracerebral hemorrhage is curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Small Vessel Disease
• Hypertensive Intracerebral Hemorrhage

Drugs mentioned

• Naoxuekang Dropping Pills (Naoxuekang dropping pills)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Hypertensive Intracerebral Hemorrhage, Cerebral Small Vessel Diseases | Phase 2 | Status: NOT_YET_RECRUITING